We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRI icon
926
Herc Holdings
HRI
$5.61B
$249K ﹤0.01%
5,090
-9,719
-66% -$453K
KEM
927
DELISTED
KEMET Corporation
KEM
$248K ﹤0.01%
9,174
-105,386
-92% -$2.56M
MORN icon
928
Morningstar
MORN
$7.53B
$246K ﹤0.01%
+1,624
New +$249K
IOVA icon
929
Iovance Biotherapeutics
IOVA
$2.87B
$245K ﹤0.01%
+8,848
New +$201K
MERC icon
930
Mercer International
MERC
$39.8M
$243K ﹤0.01%
+19,785
New +$241K
WHF icon
931
WhiteHorse Finance
WHF
$146M
$243K ﹤0.01%
+17,706
New +$247K
HHH icon
932
Howard Hughes
HHH
$4.03B
$242K ﹤0.01%
+2,008
New +$223K
PHI icon
933
PLDT
PHI
$4.33B
$242K ﹤0.01%
12,066
-22,253
-65% -$466K
ATRS
934
DELISTED
Antares Pharma, Inc.
ATRS
$242K ﹤0.01%
51,487
+33,312
+183% +$136K
GTT
935
DELISTED
GTT Communications, Inc.
GTT
$241K ﹤0.01%
+21,272
New +$178K
BBD icon
936
Banco Bradesco
BBD
$36.7B
$238K ﹤0.01%
+35,343
New +$221K
IONS icon
937
Ionis Pharmaceuticals
IONS
$9.4B
$238K ﹤0.01%
3,939
-111,832
-97% -$6.66M
LPG icon
938
Dorian LPG
LPG
$1.96B
$238K ﹤0.01%
+15,410
New +$203K
MCK icon
939
McKesson
MCK
$101B
$238K ﹤0.01%
+1,725
New +$244K
AMRX icon
940
Amneal Pharmaceuticals
AMRX
$5.79B
$237K ﹤0.01%
+49,021
New +$170K
CNDT icon
941
Conduent
CNDT
$264M
$237K ﹤0.01%
+38,205
New +$239K
TRUE
942
DELISTED
TrueCar
TRUE
$236K ﹤0.01%
+49,749
New +$208K
BLK icon
943
Blackrock
BLK
$176B
$233K ﹤0.01%
462
-663
-59% -$315K
DKS icon
944
Dick's Sporting Goods
DKS
$18.7B
$230K ﹤0.01%
+4,656
New +$198K
INSM icon
945
Insmed
INSM
$28.6B
$228K ﹤0.01%
9,539
-29,176
-75% -$593K
USPH icon
946
US Physical Therapy
USPH
$1.22B
$227K ﹤0.01%
+1,989
New +$248K
CIT
947
DELISTED
CIT Group Inc.
CIT
$227K ﹤0.01%
4,970
-290,046
-98% -$13M
FC icon
948
Franklin Covey
FC
$246M
$226K ﹤0.01%
+7,011
New +$254K
DENN
949
DELISTED
Denny's
DENN
$225K ﹤0.01%
+11,329
New +$233K
LOB icon
950
Live Oak Bancshares
LOB
$1.97B
$225K ﹤0.01%
+11,859
New +$219K
36 37
38
39 40

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.